Background: Diabetes mellitus (DM) is the commonest complication of pregnancy, negatively impacting mothers and fetuses. Few studies suggest amelioration of negative outcomes of DM-associated pregnancies in recent years, due in part to improved care. But increasing prevalence of overweight in developed countries is also affecting many women of childbearing age with concomitant poor glycemic control especially in pregnancy. Hyperglycemia, even at sub-diabetic levels, is associated with increased risk of macrosomia and Cesarean section. There is evidence demonstrating that outcomes of DM-associated pregnancies are similar with those characterized by hyperglycemia of sub-diabetic levels. Perhaps, improvement of care for DM-associated pregnancies on one hand, and the impact of obesity epidemic may have changed the relative frequencies of negative outcomes typically reported for infants of diabetic mothers (IDMs) compared with controls.
INTRODUCTION
Diabetes mellitus (DM) is one of the most common medical complications of pregnancy. A significant increase in preexisting diabetes during pregnancy has been observed in the USA between 1999 and 2005, rising from 10% to 21% [1] . Diabetes in pregnancy causes alterations from fertilization through all pregnancy period and even after its end. It predisposes the fetus to many alterations in organogenesis and growth [1] . Perinatal outcome is related to the onset and duration of glucose intolerance and to the severity of the disease. The White classification, which is based upon age of onset and duration of maternal diabetes and the presence of vasculopathy, is used to estimate prognosis and risk factors for fetal compromise [2, 3] .
Few recent reports suggest a reduction in relative frequencies of some of the adverse outcomes associated with pregnancy complicated by DM. According to German population-based data on *Address correspondence to this author at the Department of Pediatrics, Pines Women and Children's Center, Caribou Maine, USA; Tel: +12074981316; Fax: +12074981697; E-mail: u4chy2002@yahoo.co.uk 2,292,053 deliveries between 1987 and 2007 which assessed temporal trends for various pregnancy outcomes in consecutive 7 year intervals, the prevalence of stillbirths, premature delivery and macrosomia decreased over time in diabetic mothers as did the respective odds ratios [4] . So, they posited that although the risk of adverse pregnancy outcomes is still increased in diabetic mothers, considerable improvement has been achieved possibly due to improved diabetes care [4] .
On another hand there is an increasing degree of overweight and obesity in developed countries including the US, with a 2009-2010 estimate that 35.7% of US adults were obese [5, 6] . The average body mass index (BMI) is increasing in all categories, and women enter pregnancy at higher weights [7] [8] [9] [10] . Obesity has several significant complications in pregnancy including impaired glucose tolerance and development of frank diabetes mellitus. Increased glucose levels, even below the threshold for gestational diabetes, for example, are associated with increase in the risk of macrosomia and Cesarean section as described by Sermer et al. [11] and by the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study [12] . Any degree of hyperglycemia on the fetal tissues stimulates insulin secretion that can cause hypertrophy of insulin-sensitive tissues such as adipose tissue, skeletal and myocardial muscle, hepatic tissues and even islets of Langerhans in the pancreas. This leads to accelerated fetal growth and eventually macrosomia.
We propose that better glycemic control in recent years and improved diabetic care may have had some impact on the relative frequencies of negative outcomes of pregnancies among women with diabetes compared with non-diabetic pregnancies. Conversely, the increasing prevalence of overweight and obesity in developed countries leading to concomitant poor glucose metabolism could amount to increased risk level for developing similar negative outcomes among infants of non-diabetic mothers. In this study we set out to evaluate if there is still any difference in frequencies of negative outcomes among infants of diabetic mothers and those of matched non-diabetic mothers born in our community in the past year.
PATIENTS AND METHODOLOGY

Study Design
We conducted a retrospective cohort analysis. The primary exposure of interest is being born by mother with diabetes in pregnancy. The exposed arm (primary study group) consisted of mother-infant dyads consisting of babies born to mothers with diabetes mellitus in the preceding 15-month period, whose data were complete within the newly-implemented electronic health records system at The Brooklyn Hospital Center (TBHC). Controls were babies born over the same time period to mothers without diabetes.
Sampling Method
Cases were identified from the electronic health records database of the Health Information Management (HIM) Department of TBHC using the ICD-code for 'infant of diabetic mothers' (ICD-775.0) or related codes. All babies born to mothers with a diagnosis of DM in pregnancy (infants of DM mothers, IDMs) were identified and included into the study. Controls (non-IDMs) were identified systematically from a list of all babies who were born over the same period as the cases (April 2011 to June 2012).
There were 2690 babies born over the given period. Of these 50 were IDMs and were all included in the analysis. After exclusion of the IDMs, we did a random selection of the non-IDMs taking the first and every consecutive 30 th baby on the list generated from the HIM department. From the electronic medical records of the babies we identified the mothers of each babies and using the search function, accessed the records of the mothers of the selected babies.
Cut off for various parameters of interest as our outcome measures were set according to already established and well-known standards in clinical practice. Term pregnancy is defined as pregnancy reaching at least 37 completed weeks. Macrosomia is defined as any baby weighing at least 4000 grams at birth. Polycythemia is taken as hematocrit of at least 65% or hemoglobin of at least 20 g/dl. Chemical hyperbilirubinemia in the neonatal period is taken as serum bilirubin above 5mg/dl. However, depending on other clinical and laboratory parameters treatment for hyperbilirubinemia in the neonatal period is usually based on a combination of factors and will be at variable levels.
All the electronic charts of the babies and their mothers were reviewed and appropriate data extracted using a study form (Appendix I).
The study was approved by the Institutional Review Board (IRB) of The Brooklyn Hospital Center. Strict guidelines regarding good clinical practice in research and Health Information Protection and Privacy Act (HIPPA) standards were met. Data extraction was done without any personal identifiers of patients.
Statistical Analysis
Data was entered and analyzed on Statistical Package for Social Sciences (SPSS) version 21.0. Data are presented in tabular formats. Categorical or discrete data were compared by chi-square testing of the distribution, while continuous variables were compared by performing the Student t-test. The contribution of various independent factors on the outcome measures was assessed by multivariate logistic regression analysis. The significance level was set at a p-value of <0.05.
RESULTS
One hundred and thirty three (133) mother-infant dyads were recruited into the study. Of these, 50 mothers had diabetes in pregnancy while 83 mothers were non-diabetics. The characteristics of the study participants (mothers and babies) according to history of DM in pregnancy are shown in Table 1 . Of the 50 women with DM 36 (73.5%) had gestational diabetes (GDM), while 13 had pre-gestational DM (PGDM); data was missing for 1 mother. Among 36 mothers diagnosed with GDM 18 were GDMA1 (diet-controlled) while 16 were GDMA2 (medication-controlled) by White's Classification. Classification for 2 mothers was unidentifiable.
A. Maternal Age Statistics
Mean maternal age was 29.0 (± 6.4) years for entire study population. The minimum, maximum, median and modal ages were 17, 47, 29 and 25 years respectively.
Mothers with DM in pregnancy tended to be slightly older (30.6 ±7.0 years) than non-diabetic mothers (28.4 ±5.9 years) but there was no statistically significant difference between both groups. See Table 1 .
B. Maternal Anthropometric Parameters
Average Maternal Weights, Heights and BMI at Time of Delivery
Mothers with diabetes in pregnancy had higher weight in comparison with non-diabetic mothers but the average heights of non-diabetic mothers (1.65 ± 0.04 m) were greater compared with diabetic mothers (1.63 ± 0.06 m) and this was statistically significant. BMIs were greater among diabetic mothers in comparison with controls.
C. Pregnancy Outcomes
C. i. Mode of Delivery
Sixty five (65, 48.9%) babies were born by vaginal delivery and 68 (51.1%) by Caesarean section (C/S). More babies born by mothers with history of DM in pregnancy were delivered by C/S (36/49; 73.5%). The relative risk for delivery by C/S was 2.7 for mothers with DM in pregnancy compared with non-DM mothers; i.e. mothers with DM were almost 3 times more likely to deliver by C/S when compared with controls.
C. ii: Influence of Maternal Anthropometric Parameters on Mode of Delivery
Overall, mothers who delivered by C/S had higher mean weight and BMI but lower height at delivery when compared with those who had their babies by vaginal delivery. However, only the difference in mean weights between women who delivered by C/S (92.75kg) and those who had normal vaginal delivery (84.36kg) was statistically significant; {t-test = 2.329, p = 0.022; 95% CI -15.52 to -1.25}.
We conducted a logistic regression analysis of the influence of various maternal factors including history of DM, maternal age and BMI on the mode of delivery. A tabular presentation of this relationship is shown in Table 2 Even after controlling for the influence of age and BMI, women with DM in pregnancy were still at higher risk of delivering by C/S. However, maternal age and BMI were not significant predictors of delivery by C/S when the effect of history of DM in pregnancy was controlled. In fact IDMs are almost 16 times more likely to be delivered by C/Sxn compared to non-IDMs after adjusting for effects of maternal ages and BMI at delivery.
C. iii. Gestational Age (GA) at Delivery
We evaluated duration of pregnancy in terms of maturity, a more useful outcome measure than absolute number of weeks of pregnancy. More babies of mothers with DM in pregnancy (11 in number) were born preterm (<37 completed gestational weeks) compared with infants of non-diabetics (9) 
D. Clinical Status of Babies
D. i. APGAR Scores
Most babies (126/133, 94.7%) had a 1-minute Apgar score of 7 or higher, and similarly so at 5 minute with 130/133 (97.7%) having a score of at least 7. No statistically significant difference was noted for Apgar scores at 1 and 5 minutes between both study groups.
D. ii. Babies' Anthropometric Parameters
Babies born to diabetic mothers were significantly heavier than controls; mean weights of 3621.10 ±760.50 grams and 3185.04 ±543.41 respectively. Seventeen (17) 
E. Immediate Post-Natal Disposition
Significantly higher numbers of IDMs were admitted to the neonatal intensive care unit (NICU) compared with controls. Relative risk for admission to the NICU for IDMs compared with non-IDMs was 6.3. That is, IDMs were 6 times more likely to be admitted to the NICU compared with non-IDMs. A multivariate logistic regression was done to adjust for the effect of maternal age and BMI, birth weight and maturity (term versus preterm) as possible predictors of disposition of care. This is represented by the expression below and shown in Table 4 : Being born by a woman with DM in pregnancy and prematurity appeared to be the only significant predictors of admission to the NICU. However, maternal age, BMI and baby's birth weight were not significant predictors of admissions to NICU even after controlling for maternal history of DM and prematurity.
F. Birth Defects
There were nine (9) babies with identified birth defects among the study population and these occurred only among IDMs. The incidence (proportion) of defects among IDMs was 9/50 or 4.5%. The documented defects included: Ventricular septal hypertrophy (4), hypertrophic cardiomyopathy (2), biventricular hypertrophy (1), septal defects (1), persistent ductus arteriosus (PDA) in combination with patent foramen ovale (PFO) and peripheral pulmonic stenosis (PPS) in 2 babies, microphthalmia (1), Erbs Palsy (1), Neonatal tooth (1). Of note, more than one defect was observed in some of the nine (9) babies who showed any defect. Table 1 )
G. Comorbidities Developed (see
We considered hyperbilirubinemia, hypoglycemia, polycythemia, hypocalcemia, respiratory distress and sepsis as important comorbid conditions affecting outcome. Fifty-four (54/133, 41.2%) babies developed co-morbid conditions among the study population. Of the 54 babies with observed co-morbid condition, 43 were IDMs while only 11 were born to mothers without DM. There is a significant association between development of co-morbidity and being born by mother with DM in pregnancy with a relative risk of 6.6 compared to non-IDMs.
G. i. Hyperbilirubinemia
Average total bilirubin levels were higher among IDMs compared with controls with statistically significant difference (p < 0.05). Forty (40) out of 50 IDMs and 65/83 non-IDMs had total bilirubin (TB) 
G. ii. Hypoglycemia
Mean blood glucose levels at birth or within first hour post-partum was higher among non-IDMs (79.7 mg/dl ± 14.5) than IDMs (63.7 mg/dl ± 20.2) with a statistically significant difference. More importantly, whereas there were 15 cases of hypoglycemia among IDMs none of the controls had a documented hypoglycemia.
G. iii. Polycythemia
Average hematocrit values were higher among IDMs (52.6% ± 6.0 versus 48.5% ± 5.0) and this was also statistically significantly different. Five (5) babies among the IDM group had hemoglobin levels greater than 20gm/dl while none was observed among nonIDMs.
G. iv. Hypocalcemia
Mean serum calcium levels were slightly lower among non-IDMs (8.23 mg/dl ± 1.2) in comparison with IDMs (8.90 mg/dl ± 1.3) but this was not statistically significant (p = 0.164). However, 11 of the 50 IDMs and 5 out of 83 non-IDMs were documented to be hypocalcemic giving a relative risk of 3.6 for IDMs to develop hypocalcemia.
G. v. Respiratory Distress
There were twenty (20) babies among the IDMs who developed respiratory distress of various degrees compared with 6 of the 83 infants of non-diabetic mothers. IDMs were almost 5 times (RR = 4.7) more likely to have respiratory distress compared with nonIDMs.
G. vi. Suspected/Proven Sepsis
Significantly, more IDMs (21/50 IDMs) were suspected to have sepsis compared with 9/83 nonIDMs, though most were never proven, microbiologically. The relative risk for IDM to develop signs and/or symptoms suggesting a diagnosis of sepsis was about 4 compared with non-IDMs.
H. Total Duration of Hospital Stay (Table 1)
Data regarding total duration of hospital stay was complete for 50 IDMs and 79 non-IDMs. Mean number of hospital days for IDMs was 5.7 days ± 3.6 as against 2.9 days ± 1.7 for non-IDMs. The difference was statistically significant {t-test = 5.87; p = 0.000; 95% CI = 1.9 -3.7}.
DISCUSSION
The average ages of both diabetic and non-diabetic mothers were comparable, with the former being slightly older. Women with DM had higher weights at time of delivery but were shorter, thus giving higher BMIs for diabetic mothers. Our study showed that women with DM were 3 times more likely to deliver by C/S compared with controls. Several studies have documented similar findings [13] [14] [15] [16] [17] [18] . One primary reason for increased rate of delivery by C/S is due to high rate of macrosomia among women with DM in pregnancy [19] . We lack data on the relative numbers of elective versus emergency C/S. Also we cannot say how many of those delivered by C/S were done on account of fetal macrosomia. The various complications of pregnancies associated with DM including vascular changes of the placenta and poor fetal development may contribute to this outcome.
Women from both study groups who had higher weights and BMIs at delivery were more likely to deliver by C/S. Considering the possible influence of weight and BMIs along with increasing maternal age on mode of delivery we conducted a multivariate logistic regression for predictors of mode of delivery. Only maternal history of DM in pregnancy was a significant predictor. Thus, after controlling for the effect of maternal age and weight/BMI, IDMs were still about 16 times more likely to be born by C/S compared with nonIDMs. Obesity as a contributor to delivery by C/S has been well documented by Minsart et al. [17] in a population-based study in Belgium but this was not borne out in our study population. It may well be that the DM in pregnancy had an overshadowing effect on the impact of overweight and obesity on mode of delivery. A better assessment would have been the pre-conception weight or weight gain throughout pregnancy but these are often not available or only obtained by requesting women to recall their preconception weight at the time of initial booking for prenatal care, which introduces some errors.
Interestingly there was no difference in terms of the gestational age of babies at delivery. Average GAs of delivery was 37.69 weeks and 38.64 weeks for IDMs and non-IDMs respectively. Though women with DM in pregnancy had relatively more preterm deliveries (11 vs. 7) this was not significant. Many earlier studies have shown a tendency for IDMs to be delivered relatively earlier than those of none diabetic mothers [18, 19] . Often it is thought to be due to the complications arising in pregnancies associated with diabetes which cause impairment in placental vascular function. Most mothers in our studies were of White Class A1 and A2. In fact most of these were GDMs. These are more likely to have milder disease and expectedly would not have developed the vascular complications that arise from long-standing DM. We believe this may mean overall less complicated pregnancies. On another hand the fact that even those with pre-gestational DM had only class A1 and A2 DMs may allude to overall better controls and support our proposition that better control of DM would amount to less negative outcomes as demonstrated by most diabetic mothers being able to carry their pregnancies to term or near term. Furthermore, the increasing use of ultrasonographic fetal monitoring protocols to care for pregnant women with associated medical complications allows the obstetrician the ability to detect fetal complications that might prompt early delivery while also being able to allow those without any detected problems to proceed further. Thus, better care for pregnancies associated with DM would mean being able to have more mature babies born at term.
Another positive finding from our study population was the similarity of the APGAR scores of both groups at 1 and 5 minutes post-partum. Similar findings have been reported by Wahabi et al. [20] in Saudi Arabia. A significant number of our mothers were delivered by C/S, especially those with DM and according to a recent report it has been shown that delivery by C/S, especially if done electively, is associated with improved neonatal outcomes in terms of better APGAR scores at 5 minutes and lower rates of birth injuries [21] .
IDMs were heavier than those born to non-diabetic mothers with overall mean weights of 3621.1grams and 3185.0grams respectively. Seventeen of the IDMs were macrosomic (birth weight 4000grams) and there was a statistically significant difference between both study groups in terms of number of macrosomic babies. This is well documented in literature [20] . The primary reason proposed for macrosomia is the effect of uncontrolled maternal hyperglycemia which adversely influences fetal weight and growth. At moderately elevated levels of hyperglycemia macrosomia occurs, but at very high levels there is intrauterine growth restriction [21] . Other factors thought to contribute to development of macrosomia include maternal age over 30 years, prolonged pregnancy, multiparity and maternal obesity [22] . In our study even after adjusting for the effect of maternal age and mother's BMI IDMs were more likely to be macrosomic compared with nonIDMs. Large-for gestational-age babies, especially at the macrosomic range, are at increased risk of perinatal complications such as increased rate of C/S deliveries, birth injuries and asphyxia, and perinatal mortality.
IDMs were 6 times more likely to be admitted to the NICU compared with non-IDMs. Pregnancies complicated by DM are associated with several complications (comorbidities) such as hypoglycemia, polycythemia, hypocalcemia and even development of respiratory distress. This was the case with our patient population and we believe these could have played a significant role in determining admission to the NICU. A multivariate logistic regression was done to adjust for the effect of maternal age and BMI, macrosomia (birth weight) and maturity (term versus preterm) as possible predictors of disposition of care. Maternal history of DM in pregnancy and prematurity appeared to be the only significant predictors of admission to the NICU. Given that there was no significant difference in terms of gestational age of delivery between our two study groups, we then think that our analysis only demonstrated maternal history of DM in pregnancy as one significant difference between the two arms in terms of admission to the NICU. As stated earlier more IDMs have increased risk of developing some metabolic complications which often require NICU care but we cannot say whether this increase in admission to the NICU reflects a precautionary tendency as a standard protocol of care due to the anticipated complications.
Nine babies had identifiable congenital birth defects among our study population, and this occurred only among the babies born to mothers with DM in pregnancy. We documented an incidence rate of 4.5% which falls within the reported range (4 -10 times) from other studies. The pathogenesis of congenital malformations of all types in pregnant women with diabetes is very complex and has possibly a multifactorial origin [14, 23] . A strong link between hyperglycemia and malformations has been established [25] , but the precise mechanism by which it occurs has not been completely elucidated. It is supposed that hyperglycemia could cause damage to the developing yolk sac, an increased production and liberation of free oxygen radicals, deficiency of myoinositol and arachidonic acid and a disruption in signal transduction [24, [26] [27] [28] [29] . With increasing incidence of overweight and obesity in the general population and resultant metabolic derangement especially hyperglycemia [11, 12] , though not to the degree that meets the criteria for a diagnosis of diabetes, we had proposed that perhaps we might be noticing some increase in the numbers of congenital defects compared to those in pregnancies complicated by DM. This is not borne out by our findings. We think that our study size may not be enough to detect this incidence in the normal population of women without DM in pregnancy.
There was a disproportionately higher number of IDMs presenting with comorbidities including hyperbilirubinemia, hypoglycemia, polycythemia, hypocalcemia and respiratory distress. Also more IDMs were investigated for sepsis. The occurrence of these metabolic complications among IDMs is well recognized [18, 20] . Hyperbilirubinemia in IDMs is related to the development of chronic hyperinsulinism that leads to increased erythropoiesis and an accelerated hemolysis due to glycation process. Furthermore, higher incidence of prematurity with associated decreased hepatic conjugating ability and occurrence of polycythemia which increases the RBC load that are subject to hemolysis all contribute to the development of hyperbilirubinemia among IDMs. Of note is the fact that statistically significant more IDMs had hyperbilirubinemia requiring treatment.
The excess of insulin in the fetal circulation can delay pulmonary maturation associated with the low production of surfactant leading to the respiratory distress syndrome or hyaline membrane disease. Our population of IDMs had 5 times relative risk of developing respiratory distress which is comparable to the six-fold risk level reported by Kjos et al. [30] . Other factors may have contributed to this trend. More IDMs were born prematurely and also more IDMs were admitted to the NICU. Therefore, we believe that more IDMs were sicker and this may have also contributed to the development of these comorbidities. Even though more of the IDMs were evaluated for sepsis with presumptive treatment often commenced, most cases were never proven by microbiological evidence. Whereas the infants of non-diabetic mothers spent about 3 days on average in the hospital IDMs spent a significantly longer time (5.7 +/-3.6 days) before discharge. Perhaps this is one unique outcome measure that we have evaluated which has been lacking in most prior studies. The reasons derive from the various issues that complicate pregnancies and deliveries by mothers with diabetes that amount to more extensive and expensive treatment modalities. And in our hospital setting discharges of mothers or babies are not affected by each other. The duration of stay of the babies reflect the decision of the physicians directly managing them; thus the differences between duration of hospitalization in both study arms would truly reflect issues arising principally from the medical conditions alone. One major concern regarding the management of IDMs then becomes the issue of the attendant cost arising from the level of care that is often required. Increased comorbidities imply increased laboratory investigations as well more expense in terms of time and treatment. Evaluating the cost implications of management of children born to mothers with DM would indeed demonstrate the added burden to the health care system and this perhaps might provide more impetus for optimizing the care of women with diabetes.
A very interesting trend is evident in our study population. Most of the women with DM in pregnancy had gestational DM without prior mention of being diabetic. And these were also of higher BMIs. Thus, even though most of our 'diabetic' mothers may have started off as being non-diabetic, due to the metabolic burden of obesity and pregnancy many of them eventually developed gestational diabetes. Our assumption was that increasing overweight/obesity in our population may be shifting the trend of outcome of pregnancies for both diabetic and non-diabetic mothers. The observation in our study (which is retrospective) is that women who ended up having IDMs were predominantly obese, non-diabetic mothers at the outset. If this were a prospective cohort study perhaps these women developing GDM would have to be dropped out or crossed over to the other arm. We may have demonstrated the fact that obesity/ overweight is truly and significantly changing the trend with respect to creating more diabetic mothers in pregnancy who were hitherto non-diabetic. So in one sense we think that our otherwise non-diabetic mothers are actually ending up with babies who are similar to babies of mothers with pre-gestational diabetes, but this is only so because the metabolic effects of obesity have tipped them to levels similar to the pre-gestational diabetics. An interesting question to try to answer would be to know how many of these GDM that continue to have clinical symptoms of DM.
There are some evident weaknesses to our study. In attempting to have as much completed data as possible we limited our sampling frame to pregnancies and deliveries that had complete records in the newly implemented electronic health record system in our institution. This has affected the sample size of study. Also being a retrospective analysis we acknowledge that certain vital data were missed out. For instance we believe that weight gain throughout pregnancy or perhaps use of preconception weight would have been a better assessment of maternal weight but this could not be obtained in a retrospective study like ours. Overall we have demonstrated an approximation in the outcome of pregnancies of mothers with DM to those without it in terms of gestational age at delivery, excellent APGAR scores, but certain risk levels remain higher among women with pregnancies complicated by diabetes over normal pregnancies.
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